David A. Siegel Procept Bio Robotics Corp Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 26,700 shares of PRCT stock, worth $2.15 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,700
Previous 54,800
51.28%
Holding current value
$2.15 Million
Previous $3.35 Million
36.12%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$390 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$281 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$124 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$100 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$95 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.59B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...